{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:32:27Z","timestamp":1775071947090,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jhepr.2020.100143","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T21:49:46Z","timestamp":1594504186000},"page":"100143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis \u2013 The promise of DNA methylation and molecular biomarkers"],"prefix":"10.1016","volume":"2","author":[{"given":"Hege Marie","family":"Vedeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine","family":"Folseraas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guro Elisabeth","family":"Lind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9935","key":"10.1016\/j.jhepr.2020.100143_bib2","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.28529","article-title":"Aspirin use and the risk of cholangiocarcinoma","volume":"64","author":"Choi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib4","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100143_bib6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100143_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100143_bib8","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory Bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.jhepr.2020.100143_bib9","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","article-title":"Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management","volume":"13","author":"Rizvi","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.29291","article-title":"Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma","volume":"66","author":"Arbelaiz","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100143_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"Valle","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/00365521.2010.533384","article-title":"Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results","volume":"46","author":"Friman","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100143_bib14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1432-2277.2010.01108.x","article-title":"Liver transplantation for cholangiocarcinoma","volume":"23","author":"Rosen","year":"2010","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib15","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100143_bib16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"25","key":"10.1016\/j.jhepr.2020.100143_bib17","doi-asserted-by":"crossref","first-page":"17430","DOI":"10.18632\/oncotarget.24732","article-title":"Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis","volume":"9","author":"Cuenco","year":"2018","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100143_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0025-6196(12)60696-X","article-title":"Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"68","author":"Nichols","year":"1993","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mge.2002.125105","article-title":"Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"56","author":"Siqueira","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib21","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2013.08.005","article-title":"FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"59","author":"Wannhoff","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib23","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures","volume":"131","author":"Moreno Luna","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/17474124.2018.1473761","article-title":"Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis","volume":"12","author":"Taghavi","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.gie.2013.11.001","article-title":"Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Navaneethan","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gutjnl-2018-317817","article-title":"Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures","volume":"69","author":"Singhi","year":"2020","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.jhepr.2020.100143_bib28","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.humpath.2004.08.014","article-title":"Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis","volume":"35","author":"Ishikawa","year":"2004","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00428-009-0829-4","article-title":"CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma","volume":"455","author":"Kim","year":"2009","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib30","first-page":"1773","article-title":"Promoter methylation of INK4a\/ARF as detected in bile-significance for the differential diagnosis in biliary disease","volume":"9","author":"Klump","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ijc.20944","article-title":"Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors","volume":"115","author":"Tischoff","year":"2005","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5858\/2007-131-923-MPOMCI","article-title":"Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas","volume":"131","author":"Kim","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100143_bib33","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1007\/s13277-015-3147-2","article-title":"DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma","volume":"36","author":"Amornpisutt","year":"2015","journal-title":"Tumor Biol"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100143_bib34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/bjc.2011.102","article-title":"CpG-island methylation study of liver fluke-related cholangiocarcinoma","volume":"104","author":"Sriraksa","year":"2011","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100143_bib35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1349-7006.2004.tb03254.x","article-title":"Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients","volume":"95","author":"Tozawa","year":"2004","journal-title":"Cancer Sci"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100143_bib36","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4161\/epi.22191","article-title":"Novel target genes and a valid biomarker panel identified for cholangiocarcinoma","volume":"7","author":"Andresen","year":"2012","journal-title":"Epigenetics"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100143_bib37","doi-asserted-by":"crossref","first-page":"e0205864","DOI":"10.1371\/journal.pone.0205864","article-title":"Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma","volume":"13","author":"Nakamoto","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100143_bib38","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.cgh.2008.07.007","article-title":"DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease","volume":"6","author":"Parsi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib39","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.27707","article-title":"Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma","volume":"61","author":"Andresen","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib40","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1177\/1533034617748090","article-title":"DNA methylation markers improve the sensitivity of endoscopic retrograde cholangiopancreatography-based brushing cytology in extrahepatic cholangiocarcinoma","volume":"16","author":"Prachayakul","year":"2017","journal-title":"Technol Cancer Res Treat"},{"issue":"16\u201317","key":"10.1016\/j.jhepr.2020.100143_bib41","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.clinbiochem.2010.08.013","article-title":"Identification and validation of specific methylation profile in bile for differential diagnosis of malignant biliary stricture","volume":"43","author":"Zhang","year":"2010","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jmoldx.2012.01.014","article-title":"Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity","volume":"14","author":"Shin","year":"2012","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jhepr.2020.100143_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13148-016-0299-x","article-title":"Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract","volume":"8","author":"Branchi","year":"2016","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13148-019-0634-0","article-title":"Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases","volume":"11","author":"Wasenang","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","article-title":"Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib46","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/2050640616687836","article-title":"A\u00a0combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin","volume":"5","author":"Voigtlander","year":"2017","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gutjnl-2012-302047","article-title":"Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders","volume":"62","author":"Metzger","year":"2013","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100143_bib48","doi-asserted-by":"crossref","first-page":"e0139305","DOI":"10.1371\/journal.pone.0139305","article-title":"MicroRNAs in serum and bile of patients with primary sclerosing cholangitis and\/or cholangiocarcinoma","volume":"10","author":"Voigtlander","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib49","doi-asserted-by":"crossref","first-page":"e0210944","DOI":"10.1371\/journal.pone.0210944","article-title":"Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma","volume":"14","author":"Loosen","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib50","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.27050","article-title":"Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis","volume":"60","author":"Li","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100143_bib51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hep.30319","article-title":"Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma, and primary sclerosing cholangitis","volume":"70","author":"Banales","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/hep.29314","article-title":"The challenge of cholangiocarcinoma diagnosis: the turning point is in extracellular vesicles?","volume":"66","author":"Alvaro","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib53","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0002-9440(10)64262-9","article-title":"Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma","volume":"161","author":"Lee","year":"2002","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib54","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1053\/j.gastro.2006.08.034","article-title":"Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas","volume":"131","author":"Ebert","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib55","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.3800287","article-title":"Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma","volume":"18","author":"Yang","year":"2005","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100143_bib56","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1245\/s10434-013-2908-7","article-title":"P16 hypermethylation predicts surgical outcome following curative resection of Mid\/distal bile duct cancer","volume":"20","author":"Park","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib57","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.humpath.2008.11.002","article-title":"Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma","volume":"40","author":"Chinnasri","year":"2009","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib58","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/path.1139","article-title":"Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma","volume":"197","author":"Tannapfel","year":"2002","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jhepr.2020.100143_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7819-10-5","article-title":"Correlation between promoter methylation of p14(ARF), TMS1\/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma","volume":"10","author":"Liu","year":"2012","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.47.5.721","article-title":"Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver","volume":"47","author":"Tannapfel","year":"2000","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5858\/2006-130-33-PHOTPG","article-title":"Promoter hypermethylation of the p16 gene and loss of its protein expression is correlated with tumor progression in extrahepatic bile duct carcinomas","volume":"130","author":"Hong","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib62","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ijc.1639","article-title":"Inactivation of the INK4a\/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines","volume":"97","author":"Caca","year":"2002","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib63","first-page":"407","article-title":"Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma","volume":"6","author":"Liu","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00428-018-02511-7","article-title":"DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype","volume":"475","author":"Kim","year":"2019","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib65","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1478-3231.2005.01174.x","article-title":"Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas","volume":"25","author":"Foja","year":"2005","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.jhepr.2020.100143_bib66","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1158\/1940-6207.CAPR-13-0104","article-title":"Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors","volume":"6","author":"Sriraksa","year":"2013","journal-title":"Cancer Prev Res"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100143_bib67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00432-009-0646-9","article-title":"Aberrant DNA methylation of integrin alpha 4: a potential novel role for metastasis of cholangiocarcinoma","volume":"136","author":"Uhm","year":"2010","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100143_bib68","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3892\/or.2010.1089","article-title":"Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma","volume":"25","author":"Chen","year":"2011","journal-title":"Oncol Rep"},{"issue":"29","key":"10.1016\/j.jhepr.2020.100143_bib69","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.3748\/wjg.v18.i29.3849","article-title":"Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma","volume":"18","author":"Chen","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100143_bib70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2004.06.020","article-title":"Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma","volume":"217","author":"Limpaiboon","year":"2005","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib71","first-page":"446","article-title":"PCDH8 is frequently Inactivated by promoter hypermethylation in liver cancer: diagnostic and clinical significance","volume":"7","author":"Zhang","year":"2016","journal-title":"J\u00a0Cancer"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib72","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0168-8278(02)00269-6","article-title":"Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma","volume":"37","author":"Wong","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100143_bib73","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3748\/wjg.v11.i9.1333","article-title":"Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma","volume":"11","author":"Chen","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100143_bib74","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3892\/etm_00000060","article-title":"Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma","volume":"1","author":"Khaenam","year":"2010","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib75","first-page":"575","article-title":"DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma","volume":"10","author":"Dachrut","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib76","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.gastro.2006.10.037","article-title":"Sustained IL-6\/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing","volume":"132","author":"Isomoto","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100143_bib77","first-page":"449","article-title":"The methylation status of the TMS1\/ASC gene in cholangiocarcinoma and its clinical significance","volume":"5","author":"Liu","year":"2006","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib78","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.29039","article-title":"The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers","volume":"136","author":"Vedeld","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib79","doi-asserted-by":"crossref","first-page":"e97046","DOI":"10.1371\/journal.pone.0097046","article-title":"Angiopoietin-2 and biliary diseases: elevated serum, but not bile levels are associated with cholangiocarcinoma","volume":"9","author":"Voigtlander","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100143_bib80","doi-asserted-by":"crossref","first-page":"4381513","DOI":"10.1155\/2016\/4381513","article-title":"Genetic abnormalities in biliary brush samples for distinguishing cholangiocarcinoma from benign strictures in primary sclerosing cholangitis","volume":"2016","author":"Timmer","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0973-6883(11)60110-2","article-title":"Circulating CYFRA 21-1 is a specific diagnostic and prognostic biomarker in biliary tract cancer","volume":"1","author":"Chapman","year":"2011","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100143_bib82","doi-asserted-by":"crossref","first-page":"e13088","DOI":"10.1111\/eci.13088","article-title":"Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis","volume":"49","author":"Saffioti","year":"2019","journal-title":"Eur J Clin Invest"},{"issue":"9\u201310","key":"10.1016\/j.jhepr.2020.100143_bib83","article-title":"Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma","volume":"11","author":"Betesh","year":"2017","journal-title":"Proteomics Clin Appl"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100143_bib84","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cei.12776","article-title":"Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma","volume":"185","author":"Bernuzzi","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100143_bib85","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ajg.2014.60","article-title":"Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study","volume":"109","author":"Navaneethan","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100143_bib86","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s10620-014-3034-5","article-title":"Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders","volume":"59","author":"Baraniskin","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100143_bib87","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s10620-015-3596-x","article-title":"Volatile organic compounds in urine for noninvasive diagnosis of malignant biliary strictures: a pilot study","volume":"60","author":"Navaneethan","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100143_bib88","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.gie.2014.09.041","article-title":"Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592030077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592030077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:24:49Z","timestamp":1762899889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592030077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S258955592030077X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100143","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis \u2013 The promise of DNA methylation and molecular biomarkers","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100143"}}